| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |